COA Available
Performance In Stock Research Use Only
Ipamorelin
10mg · Lyophilized Powder · Purity ≥99%
Ipamorelin is a synthetic pentapeptide that selectively binds the growth hormone secretagogue receptor subtype 1a (GHS-R1a), the endogenous ghrelin receptor, and is notable for stimulating pulsatile GH release from pituitary somatotrophs in animal models without significant elevation of ACTH or cortisol. Its receptor selectivity makes it a widely used tool compound in GH axis and GHS receptor pharmacology research.
$79.99 CAD
Purchase Options
Subscriptions can be managed from your customer account. Prices in CAD.
Research Overview
Among growth hormone secretagogue compounds, Ipamorelin is characterised by its high selectivity for GHS-R1a relative to other receptor targets, resulting in a clean pharmacological profile that distinguishes it from less selective secretagogue peptides in preclinical comparative studies. This selectivity supports its use as a reference compound in assay development for ghrelin receptor pharmacology and in signalling studies examining GHS-R1a-mediated intracellular cascades. BME Health's Ipamorelin is supplied at ≥98% purity by HPLC with batch COA. Supplied exclusively for laboratory and research use.
Preclinical research has employed Ipamorelin to examine GHS-R1a receptor binding kinetics, receptor-mediated GH secretion dynamics, and downstream signalling in pituitary cell models. Animal studies have demonstrated pulsatile GH release following GHS-R1a activation without concurrent cortisol or prolactin elevation, differentiating Ipamorelin from older-generation secretagogue compounds such as GHRP-6 in comparative pharmacology studies. These properties have made it a useful benchmark compound in endocrine signalling research. All outcomes referenced pertain to preclinical models and do not constitute evidence of clinical efficacy or safety in humans.
Specifications
| Compound | Ipamorelin |
| Format | Lyophilized Powder |
| Size | 10mg |
| Purity (HPLC) | ≥99% |
| Item # | BME-IPAMOR-A |
| Storage | −20°C, dry, dark |
| Price (CAD) | $79.99 |
COA / Testing
Batch documentation and third-party testing information are available for batch BME-IPAMOR-A. COA previews appear only when documentation exists for the active batch.
Storage & Handling
Store lyophilised Ipamorelin at −20°C in a sealed vial, away from moisture and light. Avoid repeated freeze-thaw cycles to maintain peptide integrity and assay reproducibility. Reconstituted material should be aliquoted and stored at −80°C; consult the lot-specific certificate of analysis for stability guidance.
Shipping & Returns
Orders are processed on business days. Packaging is selected to maintain compound integrity in transit. Shipping timelines and return conditions are outlined in full in the Shipping & Returns policy — review before checkout if you have specific requirements. For orders with time-sensitive research schedules, contact support before placing your order.
Research Use Disclaimer
This product is supplied strictly for in-vitro and laboratory research use. It is not a drug, food supplement, or cosmetic and is not approved for human or veterinary clinical applications, diagnostics, or therapeutic use. Researchers are responsible for compliance with all applicable institutional and regulatory requirements in their jurisdiction.
Preparation Reference Guide
Research Solution Reference Calculator
Pre-filled with 10mg. Enter your solvent volume and target amount to see concentration and units on a U-100 syringe scale.
Concentration—
Volume to draw—
Syringe units (U-100)—
Per insulin unit—
For research-use calculations only. Always verify measurements independently — not medical guidance.
Questions before you order?
Browse the FAQ for documentation, storage, and sourcing answers, or contact our support team directly. We aim to respond to all research procurement inquiries within one business day.
Related
